InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.10
(
-0.04%
)
Bitcoin
63,886.66
(
-0.18%
)
Post# of 21523
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

F1ash

Send PM Follow Ignore
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

F1ash

Re: SF Wolf post# 1233

Friday, 02/24/2017 12:10:05 PM

Friday, February 24, 2017 12:10:05 PM

Post# of 21523
It always pays to scrutinize PRs carefully and not read things into them that are not implicitly stated.

Though there was certainly an important licensing agreement, my question for IR was "Is it exclusive". if I heard the reply correctly they stated it was indeed exclusive "for neurological indications".

Why is that so important... well because there are other patents out there for oral administration of Bryostatin for Alzheimer's. With an exclusive licensing agreement for synthetic Bryostatin, Neurotrope would have a "de facto" corner on the market.

If this trial provides positive data... oral administration is possible that is very important.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!